NASDAQ:NRXP | Profit Breakdown | NRX Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$1.1M-$6.51M-$16.52M
2026-03-31$1.07M-$4.74M-$1.43M
2025-12-31$983,000.00-$4.62M$360,000.00
2025-09-30$242,000.00-$4.02M-$5.89M
2025-06-30$0.00-$3.73M-$17.58M
2025-03-31$0.00-$3.85M-$5.51M
2024-12-31$0.00-$2.43M-$9.08M
2024-09-30$0.00-$3.02M-$1.62M
2024-06-30-$7.05M-$7.9M
2024-03-31-$6M-$6.53M
2023-12-31-$4.41M-$4.33M
2023-09-30-$5.81M-$6.06M
2023-06-30-$8.19M-$8.72M
2023-03-31-$3.85M-$5.51M
2022-12-31-$9.89M-$10.24M
2022-09-30-$9.14M-$9.08M
2022-06-30-$9.6M-$6.98M
2022-03-31-$15.71M-$13.45M
2021-12-31-$52.98M-$30.79M-$30.41M
2021-09-30-$20.1M-$20.77M-$37.05M
2021-06-30-$17.12M-$16.01M-$117,000.00
2021-03-31-$25.61M-$893,718.00-$25.49M
2020-12-31-$45.12M-$45.13M-$45.13M
2020-09-30-$5.15M-$5.16M-$5.16M
2020-06-30$104,819.00$102,287.00$102,287.00
2020-03-31-$119,300.00$345,848.00-$1.59M
2019-12-31-$190,959.00-$18,676.00-$14,754.00
2019-09-30-$183,305.00$74,931.00$59,195.00
2019-06-30-$175,742.00$216,697.00$176,021.00
2019-03-31-$163,181.00$219,681.00$187,965.00
2018-12-31-$322,076.00-$2,602.00$29,139.00
2018-09-30-$220,243.00$63,073.00$28,084.00
2018-06-30-$271,810.00$2,346.00-$6,602.00
2018-03-31-$192,374.00$19,596.00$15,481.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$1.23M-$16.22M-$28.62M
2024-12-31$0.00-$18.5M-$25.13M
2023-12-31$0.00-$27.84M-$30.15M
2022-12-31-$44.34M-$39.75M-$39.75M
2021-12-31-$115.8M-$93.06M-$93.06M
2020-12-31-$51.39M-$51.78M-$51.78M
2019-12-31-$713,187.00$492,633.00$408,427.00
2018-12-31-$1.01M$82,412.00$66,101.00